Studies on Resveratrol and cancer

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.
2007 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for cancer Research, cosponsored by the American Society of Preventive Oncology

Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
2005 The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
2008 The Journal of nutritional biochemistry

Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).
2003 International journal of oncology

Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
2002 Pancreas

Growth-stimulatory effect of Resveratrol in human cancer cells.
2010 Molecular carcinogenesis

Antiproliferative effect of Resveratrol in pancreatic cancer cells.
2010 Phytotherapy research : PTR

Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
2007 The Journal of surgical research

Molecular mechanisms of Resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.
2007 Molecular and cellular biochemistry

Resveratrol: a candidate nutritional substance for prostate cancer prevention.
2003 The Journal of nutrition

Regulation of p53 and cell proliferation by Resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin avß3.
2011 International journal of cancer. Journal international du cancer

Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by Resveratrol in breast cancer cells.
2001 Biochemical pharmacology

Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by Resveratrol in breast cancer cells.
2001 Biochemical pharmacology

Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation.
2007 European journal of cancer prevention : the official journal of the European cancer Prevention Organisation (ECP)

Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by Resveratrol in breast cancer cells.
2001 Biochemical pharmacology

Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by Resveratrol in breast cancer cells.
2001 Biochemical pharmacology

Role of Resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Anticancer research

Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.
2006 Journal of carcinogenesis

Resveratrol suppresses prostate cancer progression in transgenic mice.
2007 Carcinogenesis

Differential effects on growth, cell cycle arrest, and induction of apoptosis by Resveratrol in human prostate cancer cell lines.
1999 Experimental cell research

Resveratrol inhibits pancreatic cancer stem cell characteristics in human and kras transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
2011 PloS one

Cancer chemopreventive activity of resveratrol.
2002 Annals of the New York Academy of Sciences

Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells.
2003 The Journal of biological chemistry

Differential effects of Resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo.
2008 Carcinogenesis

Resveratrol inhibits migration and invasion of human breast-cancer cells.
2008 Molecular nutrition & food research

Resveratrol suppresses colitis and colon cancer associated with colitis.
2010 Cancer prevention research (Philadelphia, Pa.)

Fighting cancer with red wine? Molecular mechanisms of resveratrol.
2009 Critical reviews in food science and nutrition

Anti-cancer effect of Resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment.
2008 Advances in experimental medicine and biology

Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.
2010 Molecular nutrition & food research

Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha.
2004 Molecular cancer therapeutics

Chemoprevention of cancer and cardiovascular disease by resveratrol.
1999 Proceedings of the National Science Council, Republic of China. Part B, Life sciences

Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.
2010 Pharmaceutical research

Chemoprevention of cancer and cardiovascular disease by resveratrol.
1999 Proceedings of the National Science Council, Republic of China. Part B, Life sciences

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
2010 Human molecular genetics

Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway.
2007 Annals of the New York Academy of Sciences

Chemoprevention of cancer and cardiovascular disease by resveratrol.
1999 Proceedings of the National Science Council, Republic of China. Part B, Life sciences

Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
2006 Current drug targets

Estrogen and Resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
2007 Neoplasia (New York, N.Y.)

Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol.
2009 Molecular pharmacology

Chemoprevention of cancer and cardiovascular disease by resveratrol.
1999 Proceedings of the National Science Council, Republic of China. Part B, Life sciences

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent Resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
2004 British journal of cancer

Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray.
2003 International journal of oncology

Resveratrol-induced autophagocytosis in ovarian cancer cells.
2004 Cancer research

Repeat dose study of the cancer chemopreventive agent Resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.
2010 Cancer research

Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells.
2010 Cell biology and toxicology

Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4hydrolase.
2010 Cancer research

Molecular mechanisms of Resveratrol action in lung cancer cells using dual protein and microarray analyses.
2007 Cancer research

Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo.
2010 Cancer science

Results of a phase I pilot clinical trial examining the effect of plant-derived Resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer.
2009 Cancer management and research

Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells.
1999 Journal of cellular physiology

Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
2003 Current medicinal chemistry. Anti-cancer agents

Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol.
2004 International journal of molecular medicine

Resveratrol and derivatives for the prevention and treatment of cancer.
2010 Drug discovery today

Curcumin synergizes with Resveratrol to inhibit colon cancer.
2009 Nutrition and cancer

Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, Resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
2008 International journal of oncology

Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.
2002 The Journal of urology

Resveratrol in cancer management: where are we and where we go from here?
2011 Annals of the New York Academy of Sciences

Differential effects of Resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
2010 Molecular nutrition & food research

Resveratrol and cellular mechanisms of cancer prevention.
2011 Annals of the New York Academy of Sciences

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
2008 Cancer letters

Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
2009 Cancer prevention research (Philadelphia, Pa.)

Liposome encapsulation of curcumin and Resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
2009 International journal of cancer. Journal international du cancer

Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells.
2007 Journal of nutritional science and vitaminology

Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
2010 International journal of cancer. Journal international du cancer

Resveratrol analog, 3,5,2',4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells.
2001 Archives of pharmacal research

Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
2009 Cancer research

Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
2002 Cancer research

Resveratrol analog, 3,5,2',4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells.
2001 Archives of pharmacal research

Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells.
2005 Investigational new drugs

Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
2006 International journal of oncology

Inhibition of prostate cancer growth by muscadine grape skin extract and Resveratrol through distinct mechanisms.
2007 Cancer research

Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation.
2005 Journal of radiation research

Resveratrol analog, 3,5,2',4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells.
2001 Archives of pharmacal research

Resveratrol analog, 3,5,2',4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells.
2001 Archives of pharmacal research

Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
2007 Journal of andrology

Effect of Resveratrol on the expression of autocrine growth modulators in human breast cancer cells.
2001 Antioxidants & redox signaling

Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.
2004 Investigational new drugs

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.
2011 Cancer letters

Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells.
2006 Molecular cancer therapeutics

Protein kinase CK2 modulates apoptosis induced by Resveratrol and epigallocatechin-3-gallate in prostate cancer cells.
2007 Molecular cancer therapeutics

Comparison of the effects of the chemopreventive agent Resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
2005 International journal of cancer. Journal international du cancer

The red wine polyphenol Resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
2006 Toxicological sciences : an official journal of the Society of Toxicology

Resveratrol-induced gene expression profiles in human prostate cancer cells.
2005 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for cancer Research, cosponsored by the American Society of Preventive Oncology

Transport of a cancer chemopreventive polyphenol, resveratrol: interaction with serum albumin and hemoglobin.
2007 Journal of fluorescence

Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells.
2003 Drugs under experimental and clinical research

Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1.
2011 Oncology reports

Antitumor activity of Resveratrol and its sulfated metabolites against human breast cancer cells.
2009 Planta medica

Effects of Resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.
2009 International journal of cancer. Journal international du cancer

Spontaneous and 5-fluorouracil-induced centrosome amplification lowers the threshold to resveratrol-evoked apoptosis in colon cancer cells.
2010 Cancer letters

[Inhibitory effect of Resveratrol on the growth of human colon cancer ls174t cells and its subcutaneously transplanted tumor in nude mice and the mechanism of action].
2009 Zhonghua zhong liu za zhi [Chinese journal of oncology]

Role of non-canonical Beclin 1-independent autophagy in cell death induced by Resveratrol in human breast cancer cells.
2008 Cell death and differentiation

Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of Resveratrol in liver cancer cells.
2011 Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie

Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231.
2011 Omics : a journal of integrative biology

Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells.
2002 The Journal of nutrition

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake.
2004 Biochemical pharmacology

Low concentrations of Resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention.
2008 Molecular nutrition & food research

Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells.
2008 Photochemistry and photobiology

Expression of sulfotransferases and sulfatases in human breast cancer: impact on Resveratrol metabolism.
2010 Cancer letters

Cancer chemopreventive activity of resveratrol.
1999 Drugs under experimental and clinical research

Modulating effect of Resveratrol and quercetin on oral cancer cell growth and proliferation.
1999 Anti-cancer drugs

Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide.
2002 American journal of physiology. Gastrointestinal and liver physiology

Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol.
2004 Journal of alternative and complementary medicine (New York, N.Y.)

The novel Resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.
2011 International journal of oncology

Potent inhibitory effects of Resveratrol derivatives on progression of prostate cancer cells.
2006 Archiv der Pharmazie

Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation.
2004 Cancer detection and prevention

Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.
2006 Expert review of anticancer therapy

Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer.
2003 Anticancer research

Modulation of androgen receptor-dependent transcription by Resveratrol and genistein in prostate cancer cells.
2004 The Prostate

Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells.
2007 Biochemical pharmacology

Metabolism of Resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.
2008 Cancer letters

New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
2007 Cancer biology & therapy

Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells.
2004 British journal of cancer

Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
2001 The Journal of nutrition

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.
2003 Life sciences

Resveratrol Induces Notch2-Mediated Apoptosis and Suppression of Neuroendocrine Markers in Medullary Thyroid Cancer.
2010 Annals of surgical oncology

Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
2007 Clinical nutrition (Edinburgh, Scotland)

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9.
2006 Applied biochemistry and biotechnology

Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase.
2007 Cancer letters

Wine and resveratrol: mechanisms of cancer prevention?
2003 European journal of cancer prevention : the official journal of the European cancer Prevention Organisation (ECP)

Endocytosis of Resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.
2011 Cancer prevention research (Philadelphia, Pa.)

Effect of Resveratrol on cell cycle proteins in murine transplantable liver cancer.
2003 World journal of gastroenterology : WJG

Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling.
2003 The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Effect of Resveratrol on cell cycle proteins in murine transplantable liver cancer.
2003 World journal of gastroenterology : WJG

Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling.
2003 The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
2001 The Journal of nutrition

Bifunctional effect of Resveratrol on the expression of ErbB2 in human breast cancer cell.
2006 Cancer letters

Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells.
2007 Oncology reports

Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
2008 Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

The cancer preventative agent Resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.
2002 British journal of cancer

Estrogenic effects of Resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
2004 The Journal of steroid biochemistry and molecular biology

Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
2001 The Journal of nutrition

Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.
2008 Journal of cellular biochemistry

Effect of Resveratrol and in combination with 5-FU on murine liver cancer.
2004 World journal of gastroenterology : WJG

Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
2001 The Journal of nutrition

SOCS-3 antagonizes pro-apoptotic effects of TRAIL and Resveratrol in prostate cancer cells.
2011 The Prostate

Inhibition of cell proliferation by a Resveratrol analog in human pancreatic and breast cancer cells.
2009 Experimental & molecular medicine

[Effects of garlic oil combined with Resveratrol on inducting of apoptosis and expression of Fas, bcl-2 and bax in human gastric cancer cell line].
2008 Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Suppression of prostate cancer growth by Resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model.
2008 Asian Pacific journal of cancer prevention : APJCP

2,3',4,4',5'-Pentamethoxy-trans-stilbene, a Resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules.
2009 Biochemical pharmacology

Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice.
2010 Journal of agricultural and food chemistry

Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
2002 Clinical cancer research : an official journal of the American Association for cancer Research

Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
2003 The Journal of steroid biochemistry and molecular biology

The cancer chemopreventive agent Resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity.
1999 Archives of biochemistry and biophysics

Effect of Resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo.
2002 Biochemical and biophysical research communications

Molecular mechanisms of the chemopreventive effects of Resveratrol and its analogs in colorectal cancer: key role of polyamines?
2004 The Journal of nutrition

Resveratrol regulates insulin-like growth factor-II in breast cancer cells.
2005 Endocrinology

The cancer chemopreventive agent Resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity.
1999 Archives of biochemistry and biophysics

The cancer chemopreventive agent Resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity.
1999 Archives of biochemistry and biophysics

The cancer chemopreventive agent Resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity.
1999 Archives of biochemistry and biophysics

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
1999 Cancer research

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
1997 Science (New York, N.Y.)

Resveratrol induces apoptosis in human SK-HEP-1 hepatic cancer cells.
2009 Cancer genomics & proteomics

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
1997 Science (New York, N.Y.)

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
1999 Cancer research

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
1999 Cancer research

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
1997 Science (New York, N.Y.)

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
1997 Science (New York, N.Y.)

Resveratrol: a review of preclinical studies for human cancer prevention.
2007 Toxicology and applied pharmacology

Insulin-like growth factor II mediates Resveratrol stimulatory effect on cathepsin D in breast cancer cells.
2006 Growth factors (Chur, Switzerland)

Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
2010 Journal of agricultural and food chemistry

The chemopreventive agent Resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro.
2005 Clinical cancer research : an official journal of the American Association for cancer Research

Resveratrol--a prostate cancer chemopreventive agent?
2002 Urologic oncology

Effect of Resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
2006 Journal of experimental & clinical cancer research : CR

Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
2007 Gynecologic oncology

Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer.
2007 Molecular pharmacology

Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
1999 Cancer research

Resveratrol and breast cancer chemoprevention: molecular mechanisms.
2005 Molecular nutrition & food research

Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
2008 Nutrition and cancer

Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells.
2009 Autophagy

Inhibition of aryl hydrocarbon receptor-dependent transcription by Resveratrol or kaempferol is independent of estrogen receptor a expression in human breast cancer cells.
2010 Cancer letters

Colorectal cancer: chemopreventive role of curcumin and resveratrol.
2010 Nutrition and cancer

Analysis of Resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene.
2004 British journal of cancer

Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol.
2002 Journal of agricultural and food chemistry

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
2009 The Prostate

Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol.
2009 Journal of medicinal chemistry

Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
2007 The Prostate

Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model.
2007 Cancer letters

Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol.
2006 The Journal of biological chemistry

trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways.
2007 Genes & nutrition

Concentrations of Resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into cancer and Nutrition (EPIC)-Spain cohort.
2008 The British journal of nutrition

Synthesis of a Resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
2005 Journal of medicinal chemistry

Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.
2011 Free radical biology & medicine

Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
2003 International journal of cancer. Journal international du cancer

Treatment of ovarian cancer cells with nutlin-3 and Resveratrol combination leads to apoptosis via caspase activation.
2011 Journal of medicinal food

Role of Na(+)/H (+) exchanger in resveratrol-induced growth inhibition of human breast cancer cells.
2010 Medical oncology (Northwood, London, England)

Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional cancer Therapies.
2011 Current pharmaceutical biotechnology

The cancer chemopreventive agent Resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.
2005 Oncogene

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?
2008 Mutation research

Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.
2006 American journal of obstetrics and gynecology

Chronic treatment with Resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells.
2007 The Journal of biological chemistry

Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
2003 Carcinogenesis

Dihydroceramide intracellular increase in response to Resveratrol treatment mediates autophagy in gastric cancer cells.
2009 Cancer letters

Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
2010 Molecular nutrition & food research

Finding more active antioxidants and cancer chemoprevention agents by elongating the conjugated links of resveratrol.
2011 Free radical biology & medicine

Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.
2010 The Journal of nutrition

Antitumor effect of Resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C.
2003 Carcinogenesis

Regulation of cell survival by Resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.
2009 The Prostate

Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo.
2010 European journal of cancer (Oxford, England : 1990)

Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway.
2008 Archives of medical research

4'-Chloro-3,5-dihydroxystilbene, a Resveratrol derivative, induces lung cancer cell death.
2010 Acta pharmacologica Sinica

trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
2004 Clinical cancer research : an official journal of the American Association for cancer Research

E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.
2009 Bioorganic & medicinal chemistry

Design, synthesis, and biological evaluation of Resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
2010 Bioorganic & medicinal chemistry

Differential effect of proIGF-II and IGF-II on Resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.
2007 Growth factors (Chur, Switzerland)

Structure-activity relationships of Resveratrol and derivatives in breast cancer cells.
2009 Molecular nutrition & food research

Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent.
2008 International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition

Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
2010 The Journal of nutritional biochemistry

Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
2010 International journal of cancer. Journal international du cancer

Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
2002 The Journal of clinical endocrinology and metabolism

Non-genomic action of Resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
2007 British journal of cancer

Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop.
2006 Proteomics

Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D.
2007 Carcinogenesis

Novel Resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
2007 Anticancer research

The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and Resveratrol in in vitro drug transport models.
2007 Molecular pharmacology

Resveratrol and cancer: a review.
2002 Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie

Effect of Resveratrol and mixtures of Resveratrol and mitomycin C on cancer cells under irradiation.
2006 Anticancer research

Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB.
2005 International journal of cancer. Journal international du cancer

Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells.
2007 Pharmacology

Differential expression of genes induced by Resveratrol in human breast cancer cell lines.
2006 Nutrition and cancer

Antitumor effects of KITC, a new Resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
2009 Investigational new drugs

Novel Resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.
2008 Oncology reports

Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection.
2009 British journal of pharmacology

Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a Resveratrol structural modification.
2009 Journal of natural products

Flavonoid effects relevant to cancer.
2002 The Journal of nutrition

Inhibition of cancer growth by Resveratrol is related to its low bioavailability.
2002 Free radical biology & medicine

Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells.
2009 Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis.
2002 Pharmacological research : the official journal of the Italian Pharmacological Society

[Mechanisms of Resveratrol bovine serum albumin nanoparticle-induced cell death in human ovarian cancer SKOV3 cells].
2010 Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Inducible COX-2-dependent apoptosis in human ovarian cancer cells.
2011 Carcinogenesis

Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines.
2002 The Journal of nutrition

Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
2005 Molecular and cellular endocrinology

Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment.
2011 Cancer chemotherapy and pharmacology

Chemoprevention in experimental animals.
2011 Annals of the New York Academy of Sciences

Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
2007 Clinical cancer research : an official journal of the American Association for cancer Research